Price
$18.58+72.52%Social Signal Score
Analyst Ratings
7 analystsRevenue
$210.50M+22.31%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Sunny S. Sanyal
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 2,500
- Beta
- 0.96
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 2.27
Financials
Revenue
$210.50M+22.3%Net Income
$15.70M-28.6%EBITDA
$22.00M-39.4%Free Cash Flow
$12.00M-20.5%EPS (diluted)
$0.37-37.3%Shares Outstanding (diluted)
42.60M+13.9%Operating Expenses
$53.90MCash & Debt
$99.20MReturn of Capital
$0.00Revenue by Segment (annual)
$811.00MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $844.60M | $-70.30M | $-1.70 |
| 2024 | $811.00M | $-47.70M | $-1.17 |
| 2023 | $893.40M | $47.40M | $1.20 |
| 2022 | $859.40M | $30.30M | $0.76 |
| 2021 | $818.10M | $17.40M | $0.44 |
| 2020 | $738.30M | $-57.90M | $-1.49 |
| 2019 | $780.60M | $15.50M | $0.41 |
| 2018 | $773.40M | $27.50M | $0.73 |
| 2017 | $698.10M | $51.60M | $1.37 |
| 2016 | $620.10M | $68.50M | $1.79 |
| 2015 | $632.30M | $80.00M | $2.09 |
| 2014 | $685.20M | $110.10M | $2.88 |
| 2013 | $669.80M | $109.60M | $2.87 |
Valuation
VREXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-68.09%Social Signal Score
Mentions (5)
- Newsbusinesswire.com·24d ago·Neutral
VREX Stock Alert: Halper Sadeh LLC is Investigating Whether Varex Imaging Corporation is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Varex Imaging Corporation (NASDAQ: VREX) to Teledyne Technologies Incorporated for $18.90 per share in cash.Halper Sadeh encourages Varex shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of char…
View source ↗ - Newsdefenseworld.net·56d ago·Positive
Varex Imaging (NASDAQ:VREX) Sets New 1-Year High After Strong Earnings Varex Imaging (NASDAQ: VREX - Get Free Report) reached a new 52-week high on Monday following a better than expected earnings announcement. The company traded as high as $18.41 and last traded at $18.3850, with a volume of 1318309 shares changing hands. The stock had previously closed at $12.41. The company reported $0.31 earnings per share
View source ↗ - Newszacks.com·56d ago·Neutral
VAREX IMAGING (VREX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for VAREX IMAGING (VREX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
View source ↗ - Newszacks.com·57d ago·Positive
VAREX IMAGING (VREX) Q3 Earnings Beat Estimates VAREX IMAGING (VREX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago.
View source ↗ - Newsbusinesswire.com·57d ago·Neutral
Varex Announces Financial Results for Third Quarter Fiscal Year 2026 SALT LAKE CITY--(BUSINESS WIRE)--Varex Q3 FY26 Earnings.
View source ↗
Earnings
Tue, Nov 17(in 6 weeks)
Consensus estimate $0.33 per share
Typical surprise +75.0% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 10$0.31 vs $0.21beat
- Thu, May 7$0.21 vs $0.22miss
- Tue, Feb 10$0.19 vs $0.14beat
- Tue, Nov 18$0.37 vs $0.18beat
- Thu, Aug 7$0.18 vs $0.04beat
- Thu, May 8$0.26 vs $0.14beat
Estimates and results for VREX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by VREX officers and directors.
- Bought
- —
- Sold
- $2.8m
0 trades
8 trades
- Kunkel Jay K.sold
- Maheshwari Shubhamsold
- Kunkel Jay K.sold
- Aranki Karen Lsold
- Kunkel Jay K.sold
- Kunkel Jay K.sold
- Sanyal Sunnysold
- Honeysett Kimberley E.sold
92 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in VREX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.